Annual Revenue,rose 8.92%, in the last year to ₹3,895.14 Cr. Its sector's average revenue growth for the last fiscal year was 9.78%.
Annual Net Profit,rose 56.12% in the last year to ₹927.58 Cr. Its sector's average net profit growth for the last fiscal year was 34.97%.
Return on Equity(ROE),for the last financial year was 47.53%, more than 20% in the last financial year, indicating an efficient use of shareholder's capital to generate profit.
Glaxosmithkline Pharmaceuticals Limited is engaged in research, manufacture and make available a broad range of medicines and vaccines that benefit people. The company’s Pharmaceuticals business has a broad portfolio of innovative and established medicines with commercial leadership in anti-infectives and dermatology. Its R&D approach focuses on science related to the immune system, use of genetics and advanced technologies. Meanwhile, Its Vaccines business has a broad portfolio and innovative pipeline of vaccines to protect people of all ages. The company is the leaders in India in the private segment.
Grow your wealth with more research recommendations